The prevalence of neutralizing antibodies against adeno-associated virus capsids is reduced in young Japanese individuals-Reference-Cited by-同舟云学术

The prevalence of neutralizing antibodies against adeno-associated virus capsids is reduced in young Japanese individuals

Published:2013-10-17 Issue:11 Volume:86 Page:1990-1997
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:J. Med. Virol.

Author:

Mimuro Jun¹,Mizukami Hiroaki²,Shima Midori³,Matsushita Tadashi⁴,Taki Masashi⁵,Muto Shinji⁶,Higasa Satoshi⁷,Sakai Michio⁸,Ohmori Tsukasa¹,Madoiwa Seiji¹,Ozawa Keiya²,Sakata Yoichi¹

Affiliation:

1. Division of Cell and Molecular Medicine; Center for Molecular Medicine; Jichi Medical University; Shimotsuke Japan

2. Division of Genetic Therapeutics; Center for Molecular Medicine; Jichi Medical University; Shimotsuke Japan

3. Department of Pediatrics; Nara Medical University; Kashihara Japan

4. Department of Blood Transfusion; Nagoya University Hospital; Nagoya Japan

5. Department of Pediatrics; St. Marianna University School of Medicine, Yokohama City Seibu Hospital; Yokohama Japan

6. Department of Pediatrics; St. Marianna University School of Medicine; Kawasaki Japan

7. Division of Hematology, Department of Internal Medicine; Hyogo College of Medicine; Nishinomiya Japan

8. Department of Pediatrics; School of Medicine; University of Occupational and Environmental Health; Kitakyushu Japan

Publisher

Wiley

Subject

Infectious Diseases,Virology

Reference32 articles.

1. The AAV vector toolkit: Poised at the clinical crossroads;Asokan;Mol Ther,2012

2. Enhancing the clinical potential of AAV vectors by capsid engineering to evade pre-existing immunity;Bartel;Front Microbiol,2011

3. Prevalence of serum IgG and neutralizing factors against adeno-associated virus (AAV) types 1, 2, 5, 6, 8, and 9 in the healthy population: Implications for gene therapy using AAV vectors;Boutin;Hum Gene Ther,2010

4. Worldwide epidemiology of neutralizing antibodies to adeno-associated viruses;Calcedo;J Infect Dis,2009

5. Changing pattern of hepatitis a virus epidemiology in an area of high endemicity;Campagna;Hepat Mon,2012

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recombinant adeno-associated virus 8 vector in gene therapy: Opportunities and challenges;Genes & Diseases;2024-01

2. Prevalence of Adeno-Associated Virus-9-Neutralizing Antibody in Chinese Patients with Duchenne Muscular Dystrophy;Human Gene Therapy;2024-01-01

3. Awareness of individual goals, preferences, and priorities of persons with severe congenital haemophilia A for a tailored shared decision-making approach to liver-directed gene therapy. A practical guideline;Blood Reviews;2023-11

4. Efficient gene transduction in pigs and macaques with the engineered AAV vector AAV.GT5 for hemophilia B gene therapy;Molecular Therapy - Methods & Clinical Development;2023-09

5. Therapeutic strategy for Fabry disease by intravenous administration of adeno‐associated virus 2 or 9 in α‐galactosidase A‐deficient mice;The Journal of Gene Medicine;2023-06-30